‘Overuse’ is causing healthcare insurer headwinds, says Mizuho’s Jared Holz

Jared Holz, Mizuho healthcare equity strategist, joins CNBC’s ‘The Exchange’ to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.